Correlating Early FDG PET/CT and ctDNA in Immune Checkpoint Inhibitor (ICI)-Treated Melanoma Patients

Clinical trial NCT06199713 · RECRUITING

Trial details

NCT number: NCT06199713
Sponsor: University of Wisconsin, Madison
Status: RECRUITING
Study type: OBSERVATIONAL

Melanoma Melanoma Stage III Melanoma Stage IV Unresectable Melanoma

Start date: 2024-01-30
Primary completion: 2027-01-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.